In which patient populations or clinical situations should a Z‑score be used on dual‑energy X‑ray absorptiometry (DXA) scans instead of a T‑score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Use Z-Score in DXA

Z-scores should be used instead of T-scores in premenopausal women, men under age 50, and all children/adolescents, as WHO diagnostic criteria for osteoporosis based on T-scores do not apply to these populations. 1, 2

Primary Populations Requiring Z-Score Interpretation

Age and Sex-Based Criteria

  • Premenopausal women: Z-scores are mandatory for bone density interpretation, as T-score-based osteoporosis diagnosis is inappropriate in this population 1, 2
  • Men under 50 years of age: A diagnosis of osteoporosis cannot be made based on BMD alone using T-scores; Z-scores must be used instead 2, 3
  • Children and adolescents: The diagnosis should not be based solely on densitometric criteria and requires Z-score assessment combined with overall bone health evaluation including fracture history 2

Diagnostic Threshold

  • A Z-score ≤ -2.0 is defined as "below the expected range for age" in premenopausal women and men under 50, and mandates immediate investigation for secondary causes of bone loss 2, 3

Clinical Scenarios Requiring Z-Score Assessment

Secondary Osteoporosis Evaluation

Z-scores are essential for detecting secondary causes of bone loss in younger patients with: 2

  • Chronic renal failure
  • Rheumatoid arthritis
  • Eating disorders
  • Organ transplantation
  • Prolonged immobilization
  • Gastrointestinal malabsorption
  • Endocrine disorders (hypogonadism, hyperthyroidism, hyperparathyroidism, Cushing's syndrome)

Medication-Related Bone Loss

Z-scores should be used for younger patients receiving: 2

  • Glucocorticoid therapy
  • Androgen deprivation therapy
  • Aromatase inhibitor therapy
  • Chronic heparin
  • Anticonvulsant drugs

Whole Body Composition Assessment

  • Both Z-scores and percentiles are appropriate report outputs for whole body composition measurements when derived using methods to adjust for non-normality 1
  • For defining "low lean mass," Z-scores should be derived from a young adult, race, and sex-matched population using appendicular lean mass divided by height squared (ALM/height²) 1

Critical Interpretation Points

Population-Specific Considerations

  • Z-scores should be population-specific where adequate reference data exist 2
  • Patient's self-reported ethnicity should be used in Z-score calculations 2

Common Pitfalls to Avoid

  • Never use T-scores to diagnose osteoporosis in premenopausal women or men <50 years 2, 3
  • Do not apply WHO T-score criteria to populations where Z-scores are indicated 2
  • Avoid using screening codes for patients with low Z-scores; instead use codes for "bone density below expected range for age" when Z-score ≤ -2.0 3
  • Do not diagnose "osteoporosis" based on Z-score alone without documented fragility fractures 3

Diagnostic Nuances

  • Even without meeting full diagnostic criteria for osteoporosis, a low Z-score in a young adult is abnormal and requires action, as this indicates failure to achieve optimal peak bone mass 3
  • The diagnosis of osteoporosis in young adults cannot be made on densitometric criteria alone and requires both low bone density and the presence of fragility fractures 3
  • Z-score interpretation should prompt investigation for secondary causes of bone loss when values are below expected range 2

Monitoring Considerations

  • When performing repeat DEXA scans, compare actual bone mineral density values between scans, not Z-scores, as Z-scores change with age 3
  • Repeat DEXA scanning every 1-2 years on the same device to assess whether bone density is improving, stable, or declining 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Interpreting T-scores for Osteoporosis Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bone Density Interpretation in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.